Grupo Clínico Asociado en Farmacia

Área de

Implementation of a new therapeutical drug monitoring system in a clinical analytical laboratory for pharmacokinetic control of antibiotic, antifungal and antineoplastic agents in the hospitalized patient, with the aim of optimal and rational use of pharmacological treatment

Observational Study of population pharmacokinetic model of voriconazole in allogeneic stem cell transplantation. Study approved by the Spanish Agency for Medicine and Health Products with code CSV-VOR-2014-01

Study of Physico-chemical stability of a new mycophenolate mofetil intravenous solution in polypropylene infusion bag at different storage conditions

Study of pharmacokinetics of caspofungin in patients under hemodiafiltration. Study approved by the Agencia Española del Medicamento y Productos Sanitarios with code MER-CAS-2013-01

Study of pharmacokinetics of Ceftolozane in critical patients. Study pending of approval by the Agencia Española del Medicamento y Productos Sanitarios with code CEFT-TCRR-2017

Study of Physico-chemical stability of a new ophthalmic eyedrop formulation at different storage conditions

Coordinador
Dr. Manuel Alós Almiñana
alos_man@gva.es

INVESTIGADORES
R4 Senior

Manuel Alós Almiñana    

R3 Consolidado

Teresa Torrecilla Junyent

R2 Novel / Emergente

Carmen Carrión Carrión
Francisco Ferriols Lisart
Rafael Ferriols Lisart

R1 Predoctoral
STAFF
Colaborador/a

Carlos Ezquer Garín
Diego Cano Blanquer
Mercedes Jiménez Heredia
Raquel Pardillo Armuña

Enfermero/a
Técnico/a
Apoyo
Publicaciones
Effect of one-year dextromethorphan/quinidine treatment on management of respiratory impairment in amyotrophic lateral sclerosis. Sancho J, Ferrer S, Bures E, Diaz JL, Torrecilla T, Signes-Costa J, Servera E. Respiratory Medicine. 2021 Jul 7;186:106536. doi: 10.1016/j.rmed.2021.106536. PMID: 34260979

Health outcomes and primary adherence to secondary prevention treatment after st-elevation myocardial infarction: a spanish cohort study. Lopez A, Alos Almiñana M, Peris J. Journal of Cardiovascular Translational Research. 2021 Apr;14(2):308-316. doi: 10.1007/s12265-020-10045-0. PMID: 32557320

MUC1 intracellular bioactivation mediates lung fibrosis. Milara Paya J, Ballester B, Montero P, Escriva J, Artigues E, Alos Almiñana M, Pastor–Clerigues A, Morcillo Sánchez E, Cortijo J. Thorax. 2020 Feb;75(2):132-142. doi: 10.1136/thoraxjnl-2018-212735. PMID: 31801904

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances. Aguilar Aguilar G, Ferriols Lisart R, Martínez Castro S, Ezquer Garin C, Pastor Martinez E, Carbonell Lopez J, Alos Almiñana M, Navarro Ortega D. Critical Care. 2020 Jan 10;24(1):11. doi: 10.1186/s13054-019-2724-y. PMID: 31924240

Secondary adherence to beta-blockers after ST-elevation myocardial infarction without ventricular dysfunction. Padilla Lopez A, Alos Almiñana M, Peris J. Medicina Clinica. 2020 Sep 25;155(6):242-248. doi: 10.1016/j.medcli.2019.11.008. PMID: 31932044

Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures. Ezquer Garin C, Ferriols Lisart R, Martinez-López L, Sangrador-Pelluz C, Nicolás-Picó J, Alos Almiñana M. Pharmazie. 2020 May 1;75(5):172-176. doi: 10.1691/ph.2020.9155. PMID: 32393422